Get the latest BMRN - BioMarin Pharmaceuticals Inc stock market performance data and financial news.
Get the latest BMRN - BioMarin Pharmaceuticals Inc together with stock market performance data and financial news.
Get the latest BMRN - BioMarin Pharmaceuticals Inc stock market performance data and financial news.
Read Jim Cramer's take on BioMarin Pharmaceuticals Inc (BMRN) and get his latest thoughts on the company?s performance and outlook
Today's Short-Squeeze Plays: BMRN, As the stock closes in on its
52-week high, a potential short squeeze is on the doorstep. ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
BioMarin posts a first-quarter loss on markdowns of two investments; revenue jumps 23%.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10494707/1/biomarin-swings-to-a-loss-in-first-quarter.html
See who made what calls.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10464777/1/analysts-upgrades-downgrades-h-p.html
The company has licensed worldwide commercial rights to Riquent, an experimental lupus drug from La Jolla Pharmaceuticals.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10456368/1/biomarin-buys-rights-to-long-delayed-la-jolla-drug.html
Big Pharma is seeking deals with biotech, specialty pharma, analyst says. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10599708/1/psst-these-drug-firms-are-getting-bought-biobuzz.html
Connect with TheStreet